Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11532003rdf:typepubmed:Citationlld:pubmed
pubmed-article:11532003lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:11532003lifeskim:mentionsumls-concept:C1383501lld:lifeskim
pubmed-article:11532003lifeskim:mentionsumls-concept:C0007586lld:lifeskim
pubmed-article:11532003lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:11532003lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:11532003lifeskim:mentionsumls-concept:C1705920lld:lifeskim
pubmed-article:11532003lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:11532003lifeskim:mentionsumls-concept:C0185026lld:lifeskim
pubmed-article:11532003lifeskim:mentionsumls-concept:C1710236lld:lifeskim
pubmed-article:11532003lifeskim:mentionsumls-concept:C0521115lld:lifeskim
pubmed-article:11532003lifeskim:mentionsumls-concept:C1550605lld:lifeskim
pubmed-article:11532003lifeskim:mentionsumls-concept:C1711351lld:lifeskim
pubmed-article:11532003lifeskim:mentionsumls-concept:C0456205lld:lifeskim
pubmed-article:11532003lifeskim:mentionsumls-concept:C0166968lld:lifeskim
pubmed-article:11532003pubmed:issue17lld:pubmed
pubmed-article:11532003pubmed:dateCreated2001-9-4lld:pubmed
pubmed-article:11532003pubmed:abstractTextThe chaperonin-containing t-complex polypeptide 1 (CCT) is a cytosolic molecular chaperone composed of eight subunits that assists in the folding of actin, tubulin and other cytosolic proteins. We show here that the content of particular subunits of CCT within mammalian cells decreases concomitantly with the reduction of chaperone activity during cell cycle arrest at M phase. CCT recovers chaperone activity upon resumption of these subunits after release from M phase arrest or during arrest at S phase. The levels of alpha, delta and zeta-1 subunits decreased more rapidly than the other subunits during M phase arrest by colcemid treatment and recovered after release from the arrest. Gel filtration chromatography or native (nondenaturing) PAGE analysis followed by immunoblotting indicated that the alpha and delta subunit content in the 700- to 900-kDa CCT complex was appreciably lower in the M phase cells than in asynchronous cells. In vivo, the CCT complex of M-phase-arrested cells was found to bind lower amounts of tubulin than that of asynchronous cells. In vitro, the CCT complex of M phase-arrested cells was less active in binding and folding denatured actin than that of asynchronous cells. On the other hand, the CCT complex of asynchronous cells (a mixture of various phases of cell cycle) exhibited lower alpha and delta subunit content and lower chaperone activity than that of S-phase-arrested cells obtained by excess thymidine treatment. In addition, turnover (synthesis and degradation) rates of the alpha and delta subunits in vivo were more rapid than those of most other subunits. These results suggest that the content of alpha and delta subunits of CCT reduces from the complete active complex in S phase cells to incomplete inactive complex in M phase cells.lld:pubmed
pubmed-article:11532003pubmed:languageenglld:pubmed
pubmed-article:11532003pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11532003pubmed:citationSubsetIMlld:pubmed
pubmed-article:11532003pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11532003pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11532003pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11532003pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11532003pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11532003pubmed:statusMEDLINElld:pubmed
pubmed-article:11532003pubmed:monthSeplld:pubmed
pubmed-article:11532003pubmed:issn0014-2956lld:pubmed
pubmed-article:11532003pubmed:authorpubmed-author:YuraTTlld:pubmed
pubmed-article:11532003pubmed:authorpubmed-author:KubotaHHlld:pubmed
pubmed-article:11532003pubmed:authorpubmed-author:YokotaSSlld:pubmed
pubmed-article:11532003pubmed:authorpubmed-author:YanagiHHlld:pubmed
pubmed-article:11532003pubmed:issnTypePrintlld:pubmed
pubmed-article:11532003pubmed:volume268lld:pubmed
pubmed-article:11532003pubmed:ownerNLMlld:pubmed
pubmed-article:11532003pubmed:authorsCompleteYlld:pubmed
pubmed-article:11532003pubmed:pagination4664-73lld:pubmed
pubmed-article:11532003pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:11532003pubmed:meshHeadingpubmed-meshheading:11532003...lld:pubmed
pubmed-article:11532003pubmed:meshHeadingpubmed-meshheading:11532003...lld:pubmed
pubmed-article:11532003pubmed:meshHeadingpubmed-meshheading:11532003...lld:pubmed
pubmed-article:11532003pubmed:meshHeadingpubmed-meshheading:11532003...lld:pubmed
pubmed-article:11532003pubmed:meshHeadingpubmed-meshheading:11532003...lld:pubmed
pubmed-article:11532003pubmed:meshHeadingpubmed-meshheading:11532003...lld:pubmed
pubmed-article:11532003pubmed:meshHeadingpubmed-meshheading:11532003...lld:pubmed
pubmed-article:11532003pubmed:meshHeadingpubmed-meshheading:11532003...lld:pubmed
pubmed-article:11532003pubmed:meshHeadingpubmed-meshheading:11532003...lld:pubmed
pubmed-article:11532003pubmed:meshHeadingpubmed-meshheading:11532003...lld:pubmed
pubmed-article:11532003pubmed:meshHeadingpubmed-meshheading:11532003...lld:pubmed
pubmed-article:11532003pubmed:year2001lld:pubmed
pubmed-article:11532003pubmed:articleTitleCytosolic chaperonin-containing t-complex polypeptide 1 changes the content of a particular subunit species concomitant with substrate binding and folding activities during the cell cycle.lld:pubmed
pubmed-article:11532003pubmed:affiliationHSP Research Institute, Kyoto Research Park, Shimogyo-ku, Kyoto, Japan.lld:pubmed
pubmed-article:11532003pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:60entrezgene:pubmedpubmed-article:11532003lld:entrezgene
entrez-gene:7280entrezgene:pubmedpubmed-article:11532003lld:entrezgene
entrez-gene:10376entrezgene:pubmedpubmed-article:11532003lld:entrezgene
entrez-gene:908entrezgene:pubmedpubmed-article:11532003lld:entrezgene
entrez-gene:6950entrezgene:pubmedpubmed-article:11532003lld:entrezgene
entrez-gene:10574entrezgene:pubmedpubmed-article:11532003lld:entrezgene
entrez-gene:10576entrezgene:pubmedpubmed-article:11532003lld:entrezgene
entrez-gene:10694entrezgene:pubmedpubmed-article:11532003lld:entrezgene
entrez-gene:22948entrezgene:pubmedpubmed-article:11532003lld:entrezgene
entrez-gene:12464entrezgene:pubmedpubmed-article:11532003lld:entrezgene
entrez-gene:12468entrezgene:pubmedpubmed-article:11532003lld:entrezgene
entrez-gene:22142entrezgene:pubmedpubmed-article:11532003lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11532003lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11532003lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11532003lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11532003lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11532003lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11532003lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11532003lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11532003lld:pubmed